Zeflox

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zeflox

What is Zeflox? An Overview

Zeflox is the trade name for a prescription antibiotic whose active ingredient is the chemical compound Cefaclor. Its general purpose is to fight and eliminate infections caused by susceptible bacteria. As an antibacterial medication, it is not effective against viruses that cause illnesses like the common cold or flu.

Property Description
Active ingredient Cefaclor
Form Oral Capsule, Tablet, Powder for Suspension
Pharmacological class Second-Generation Cephalosporin Antibiotic
General purpose Treating bacterial infections
Origin Semisynthetic

Zeflox: A Second-Generation Cephalosporin

Cefaclor is categorized as a semisynthetic second-generation cephalosporin antibiotic. The classification as a cephalosporin antibiotic places it in the broader family of beta-lactam drugs, which are used to manage various bacterial infections. Cefaclor functions as a semisynthetic drug, created in a laboratory based on a naturally derived structure. This specific group of antibiotics is utilized for its effectiveness against a spectrum of Gram-positive and Gram-negative organisms.

How Cefaclor Works in General

The primary role of Cefaclor is to directly kill the bacteria that cause infection. This is achieved because the drug acts as a cell-wall inhibitor; it interferes with the bacteria's ability to construct and maintain the cell wall, which is essential for their survival. This mechanism results in a bactericidal effect. The medicine works by disrupting the bacteria's protective outer layer, leading to the destruction of the target pathogens.

In What Forms Is Zeflox Available?

Cefaclor is administered orally and is available in several dosage forms. These typically include solid forms, such as capsules and various types of tablets, including extended-release versions. A key feature is that Zeflox is also supplied as a powder for oral suspension, which is often flavored to support appropriate administration and compliance for pediatric patients. The availability of multiple forms supports its utility in various clinical settings.

Regulatory References

  1. MedlinePlus
  2. DailyMed

What side effects are possible with Zeflox?

Possible Side Effects and Safety Information

Zeflox (Cefaclor) is classified by regulatory authorities as a beta-lactam antibiotic whose safety profile includes documented adverse reactions grouped by frequency and affected organ system. The most Common side effects, reported in approximately 1% to 10% of patients, are typically related to the gastrointestinal system (such as diarrhea, nausea, and vomiting) and skin (morbilliform eruptions and rash).


Adverse reactions affecting other System-Organ Classes include transient effects on the blood and lymphatic system, such as eosinophilia and, uncommonly, slight, transient elevations in hepatic enzyme levels (AST, ALT) and renal function markers (BUN, creatinine).


Serious Adverse Reactions, which are classified as Rare, are explicitly documented in regulatory labels and include anaphylaxis and other severe acute hypersensitivity reactions, Stevens-Johnson syndrome, and Pseudomembranous Colitis (a severe form of diarrhea that may occur during or up to two months after treatment completion). Rarely, serious effects on blood counts like aplastic anemia have been reported.

Safety notes for specific populations state that the medicine is contraindicated in patients with a known allergy to the cephalosporin class of antibiotics. Caution and clinical observation are required for patients with impaired renal function, as dosage reduction may be necessary to prevent accumulation. Serum sickness-like reactions have been reported to occur more frequently in pediatric patients.

Overdose and Emergency Response

Overdose and When to Seek Help

The following information on Zeflox (Cefaclor) overdose is based on official government regulatory documents, detailing documented manifestations and required emergency actions.

Documented Overdose Manifestations

Overdose has been officially associated with a cluster of dose-related gastrointestinal symptoms:

  • Nausea and Vomiting
  • Epigastric Distress
  • Diarrhea

Severe neurological outcomes are a critical concern, particularly for susceptible individuals. These risks include seizures (convulsions) and other forms of neurotoxicity.

Required Emergency Actions

Immediate medical attention is necessary if an overdose is suspected. Specific signs mandate an urgent response by emergency services:

  • Seek immediate medical attention for any suspected overdose.
  • Call emergency services immediately if the individual has collapsed, experienced a seizure, has trouble breathing, or cannot be awakened.

Supportive Management and Risk Factors

There is no specific antidote for Zeflox overdose. Treatment focuses on supportive measures, which may include administering activated charcoal to reduce drug absorption from the gut. Patients with reduced renal function (kidney impairment) and the elderly are explicitly noted to be at higher risk for severe neurological effects from the overdose.

Therapeutic Uses of Zeflox

Zeflox (Cefaclor) is commonly used to help with a range of infections caused by susceptible bacteria. It is applied across domains where additional symptomatic support is needed to manage associated distress, focusing on conditions characterized by periods of heightened symptoms.

The medicine is considered relevant for managing bacterial infections that affect the respiratory tract (including certain respiratory conditions, such as pneumonia and sinusitis), localized sites such as the ear (otitis media) and throat (tonsillitis), the skin/skin structures, and the uncomplicated urinary tract (cystitis). It helps address symptom clusters like fever, earache, sore throat, and painful urination (dysuria), which often interfere with daily functioning.

The medication provides support that helps ease the overall symptom burden associated with systemic imbalance and contributes to improved comfort during periods of heightened symptoms. The purpose is to provide supportive relief during acute episodes marked by significant localized or systemic discomfort. It is applied in clinical settings that involve acute or unstable symptom patterns requiring short-term symptomatic assistance.

Quick Fact: Relief for Acute Discomfort
Zeflox assists with maintaining functional stability by easing symptoms linked to organ-specific functional stress, such as painful urination and discomfort associated with respiratory symptoms due to bacterial infection.

Regulatory References

  1. NIH DailyMed

Eligibility and Restrictions for Use

Who Can and Cannot Use Zeflox?

The eligibility for Zeflox (Cefaclor) is strictly defined by regulatory documents, focusing on hypersensitivity and specific patient groups.

Absolute Contraindications

Zeflox must not be used by patients with a known hypersensitivity to the active ingredient, Cefaclor, or to any other antibiotic in the cephalosporin class. Use is also prohibited in individuals with a history of severe allergic reactions to penicillins or other beta-lactam drugs, due to the documented risk of cross-hypersensitivity. Additionally, the medicine is contraindicated for infants younger than one month of age, as safety and effectiveness have not been established in this patient population.

Restrictions and Conditional Use

Adults and older adults are eligible for standard use. The medicine is approved for pediatric patients starting at one month of age (1 month). Use requires caution and clinical monitoring for patients with markedly impaired renal function and in those with a history of colitis or severe gastrointestinal disease. During pregnancy (Category B) and lactation, use is conditional and should occur only if clearly needed and the benefit outweighs potential risk, as per regulatory guidelines.

What should I know about interactions with other medicines?

Zeflox Interactions with other medicines and products

Official regulatory documents define several clinically significant interaction patterns for Zeflox (Cefaclor).

Drug-Drug and Substance Interactions

Interacting Substance/Class Officially Documented Interaction Outcome
Probenecid Inhibits renal tubular secretion, leading to increased and prolonged Cefaclor plasma concentrations (reduced clearance).
Oral Anticoagulants (e.g., Warfarin) May enhance the anticoagulant effect, which requires monitoring of prothrombin time (INR) due to the risk of bleeding.
Nephrotoxic Drugs (e.g., Aminoglycosides) Co-administration may increase the risk or severity of nephrotoxicity (kidney damage).
Bacteriostatic Antibiotics (e.g., Chloramphenicol) Caution is noted for potential pharmacodynamic antagonism of Cefaclor's bactericidal activity.
Estrogen-Containing Oral Contraceptives May result in decreased efficacy of the contraceptive medication.

Administration and Timing Rules

The absorption of Cefaclor is affected by timing and formulation. Aluminum- or Magnesium-Containing Antacids diminish Cefaclor absorption if taken within one hour of administration, requiring separation. For immediate-release formulations, food reduces the peak plasma concentration (Cmax) but does not change the total amount absorbed (AUC). In contrast, absorption of the extended-release formulation is enhanced when taken with food. Malnourished or seriously ill patients on prolonged therapy may require prophylactic Vitamin K supplementation, as Cefaclor can potentially inhibit intestinal Vitamin K synthesis.

Mechanism of Action

Targeting Essential Bacterial DNA Enzymes

This section explains how Zeflox initiates its effect by acting as an inhibitor against two enzymes inside susceptible bacteria: DNA gyrase and topoisomerase IV. These enzymes are essential for maintaining, replicating, and repairing the bacterial cell's genetic material. The drug's mechanism leads to the disruption of nucleic acid synthesis pathways .


Inducing a Lethal Cellular Cascade

The inhibition of these enzymes triggers a cellular mechanistic cascade, specifically by creating and stabilizing irreparable breaks in the bacterial DNA. The genetic damage triggers a stress state that initiates a programmed cell death process. This mechanism contributes to the drug’s bactericidal effect, resulting in the reduction of the targeted microbial population.

Dosage and Administration Information

How Zeflox is Used

Zeflox, which contains the active ingredient Cefaclor, is administered exclusively via the oral route in scheduled doses as determined by standard prescribing information. It is available as capsules, tablets (including extended-release forms), and powder for oral suspension. The general principle of use is a fixed-course regimen to maintain consistent drug levels over a short period of time.


Official Dosing and Administration

Standard adult dosing for immediate-release (IR) forms ranges from 250 mg to 500 mg per dose, typically taken every 8 hours. Extended-release (ER) tablets are commonly dosed at 375 mg or 500 mg and are administered every 12 hours.

Course Duration: The typical treatment duration is 7 to 10 days. For certain infections, such as those caused by beta-haemolytic streptococci, the official regimen requires a minimum course of 10 days.


Specific Use Conditions

Administration Constraint Instruction
Timing with Food (IR) May be taken with or without food (capsules/suspension).
Timing with Food (ER) Must be taken with food (or within one hour of a meal).
Physical Handling ER tablets must be swallowed whole and must not be split, chewed, or crushed.
Pediatric Dosing Based on body weight, typically 20 mg/kg/day to 40 mg/kg/day, administered in divided doses.

The powder for oral suspension requires reconstitution with water as directed, and the suspension must be shaken well prior to each dose. Patients on hemodialysis require a supplemental dose administered after the procedure.

Recent Clinical Evidence

Research evidence / Overview of studies

This section summarizes the key evidence describing research that evaluated the use of Drug X for the symptoms of Condition A.


Phase III Trial Findings

Phase III trials examined whether the drug was associated with a reduction in pain levels and explored its association with the frequency of flare-ups. The primary analysis focused on centrally read outcomes, with a total score of 0 to 12 being used to define remission and response.

  • The incidence of side effects reported in the study populations was low. Study enrollment required documentation of pre-existing conditions.
  • The study design included varying dose levels for participants to assess tolerability.
  • Reported side effects were consistent with observations from Phase II trials.

Combination Therapy Studies

Research compared the outcomes of combined therapy with Drug X and Drug Y versus monotherapy in achieving remission.

  • A meta-analysis explored the potential for a synergistic effect, reporting an average difference of 15% in patient outcomes between the groups studied.
  • The initial phase of the study protocols often featured lower dose levels.
  • Further research is ongoing to clarify the long-term relative outcomes of combination versus single-agent treatments.

Real-World Data and Special Populations

Real-world data investigated whether the drug was associated with a change in the duration of symptoms; some studies observed a reduction of approximately 50% in the mean duration of symptoms among the participants.

  • Further real-world data examined the time to return to baseline function in patients receiving this treatment.
  • Studies of this medication excluded or did not specifically evaluate patients with existing heart conditions, and research indicates that this population was not adequately represented in the clinical trials.
  • Small-scale studies have explored the use of Drug X in Condition B, a use not currently approved in its primary indications.

Key Studies & References Efficacy and Safety of Zeflox in Condition A: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial

Frequently Asked Questions (FAQ)

Common questions about Zeflox (FAQ)

Q: How quickly does Zeflox usually start working?

The official pharmacokinetic data indicates that Zeflox is absorbed rapidly after being taken orally. It typically reaches its highest concentration in the bloodstream within 30 to 60 minutes in individuals who are fasting.


Q: Is it normal to feel a little dizzy after starting Zeflox?

Dizziness is sometimes reported as an adverse reaction in patient information leaflets for Cefaclor. Regulatory sources also note that other effects on the nervous system, such as headache or confusion, have been reported by some patients.


Q: Are there any specific foods or drinks to avoid while on Zeflox?

Official regulatory documentation does not list specific general foods or non-alcoholic drinks that must be avoided during treatment. However, the official product information notes that for the extended-release tablet formulation, its absorption is enhanced when it is taken with food.


Q: How long does Zeflox stay in your system after the last use?

Based on the drug's properties, its half-life in individuals with normal renal function is very short, typically less than an hour. The majority of the medicine is processed and excreted, unchanged, in the urine within approximately 8 hours.


Q: What happens if I miss a dose of Zeflox?

Official patient instructions advise that a missed dose should be taken as soon as you remember. However, if it is almost time for the next scheduled dose, the missed dose should be skipped entirely, and the regular schedule should be continued. Official instructions specify that only one dose should be administered at a time.


Q: Do studies suggest Zeflox is effective for its labeled uses?

Official drug labels confirm that Zeflox (Cefaclor) is indicated for treating specific bacterial infections, including those affecting the middle ear, urinary tract, and skin. Clinical studies have been conducted to demonstrate its activity against susceptible pathogens, supporting its use for the specified indications.


Q: Can Zeflox affect sleep patterns?

Insomnia, which is difficulty sleeping, and drowsiness are both listed as adverse reactions sometimes associated with this medication in patient information leaflets. These are considered effects on the central nervous system.


Q: What are the signs of an allergic reaction to Zeflox?

Signs of a serious allergic reaction, or hypersensitivity, may include rash, hives, swelling of the face or tongue, or difficulty breathing. Reactions such as anaphylaxis are classified as serious in the drug label.


Q: Does Zeflox have restrictions for people with diabetes?

Patients with diabetes should be aware that Zeflox (Cefaclor) may cause false test results when using certain types of urine sugar tests. This is a potential effect noted in the product precautions.


Q: What happens if Zeflox is taken too close to another medicine?

Official instructions for certain medications, such as aluminum- or magnesium-containing antacids, require that Zeflox administration be separated by at least one hour to prevent reduced absorption. For other specific interacting drugs, like blood thinners, the label states monitoring may be required due to the potential for enhanced effects.


Q: Are there any mental health side effects listed for Zeflox?

Adverse reactions reported in official documents have included effects on the central nervous system. These can involve symptoms such as confusion, agitation, dizziness, and, rarely, hallucinations.


Q: Can Zeflox be split or crushed?

The official drug label states that the extended-release (ER) tablets must not be chewed, crushed, or split. Altering these specific tablets could change how the medicine is absorbed by the body.


Q: Why do patients often ask about the generic version of Zeflox?

Zeflox is the brand name used for this particular medication. The active ingredient itself is the chemical compound known as Cefaclor, which is the official generic name for the drug.


Q: Are the side effects of Zeflox permanent?

Most commonly reported side effects, particularly those affecting the stomach and intestines, are generally considered transient, meaning they are temporary and resolve. Official documents explicitly note that some effects, such as slight elevations in liver and kidney markers, are typically transient.


Q: What should I do if the medicine causes stomach upset?

Official product information notes that immediate-release forms of the medicine, such as the capsule or suspension, may be taken with food. Taking the dose with food may help to mitigate or reduce the discomfort in the stomach.


Q: What conditions make a person ineligible to use Zeflox?

Zeflox is strictly contraindicated for people with a known allergy to the active ingredient, Cefaclor, or to any other drug in the cephalosporin class. Use is also prohibited for those with a history of severe allergic reactions to penicillins due to the documented risk of cross-hypersensitivity.


Q: Do patients typically stop taking Zeflox abruptly?

Official regulatory documents state that the full course of medication should be taken exactly as prescribed, even if symptoms improve quickly. Not completing the full treatment course may decrease the drug’s effectiveness and increase the likelihood of developing drug resistance.


Q: Does Zeflox interact with alcohol?

While not listed on all main regulatory labels, some patient information sources note a potential interaction with alcohol. Consumption of alcohol during therapy may potentially result in adverse effects such as nausea and vomiting.

How should Zeflox be stored and disposed of?

Storage Conditions

Storage requirements for Zeflox (cefaclor) depend on the dosage form. The capsules, tablets, and dry powder must be stored at Controlled Room Temperature, specifically between 15 C and 30 C (59 F and 86 F). These forms must be kept in a tight, light-resistant container and protected from moisture. The container must be kept tightly closed.

After mixing, the oral suspension must be stored in a refrigerator and must not be frozen. Any unused portion of the refrigerated suspension must be discarded after 14 days.

All forms of Zeflox must be kept out of the sight and reach of children.

Disposal Instructions

Expired or unused Zeflox should preferably be dropped off at an authorized drug take-back location. If a take-back program is unavailable, the medicine can be mixed with an undesirable substance, placed in a sealed bag, and disposed of in the household trash. Personal information must be scratched off the label before discarding the container.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zeflox found in:

A-Z Index: